Investment Summary

Cathay Capital Private Equity Invests In CCDI

On August 25, 2015, private equity firm Cathay Capital Private Equity invested in business services company CCDI

Investment Highlights
  • This is Cathay Capital Private Equity’s 2nd transaction in the Business Services sector.
  • This is Cathay Capital Private Equity’s 14th transaction in China.

Investment Summary

Date 2015-08-25
Target CCDI
Sector Business Services
Investor(s) Cathay Capital Private Equity
Deal Type Growth Capital

Target

CCDI

Shanghai, China
CCDI is a provider of comprehensive services covering the sectors related to the urbanization such as the residential, commercial real estate, civil projects, transportation, sports, cultural tourism and medical care, and extends to the whole industrial chain of every sector. CCDI was founded in 1994 and is based in Shanghai, China.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Cathay Capital Private Equity

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cathay Capital Private Equity SAS is a French Chinese private equity firm focused on acquiring businesses in France, Hong Kong, and China. Cathay looks to help Western companies leverage opportunities in China and help Chinese companies leverage Western best practices and partnerships. The Firm looks to invest in businesses generating €5 to €150 million in revenues. Areas of interest include retail, consumer goods, electrical equipment, medical devices, pharmaceuticals, animal healthcare, translation, food, consumer services, and software. Cathay Capital Private Equity SAS was formed in 2007 and is based in Paris. The firm has additional offices in New York and Shanghai.


DEAL STATS #
Overall 38 of 101
Sector: Business Services M&A 2 of 4
Type: Growth Capital M&A Deals 11 of 26
Country: China M&A 14 of 39
Year: 2015 M&A 8 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-10 Cenexi

Fontenay sous Bois, France

Cenexi engages in the contract manufacturing and packaging of pharmaceuticals for human and veterinary markets in the Americas, Asia, Oceania, Africa, and Europe. Cenexi was founded in 2004 and is based in Fontenay sous Bois, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-09 China Shenghuo Pharmaceutical Holdings

Kunming, China

China Shenghuo Pharmaceutical Holdings is a pharmaceutical group specialized in the field of Traditional Chinese Medicine (TCM). Shenghuo’s flagship product, the XueSaiTong (XST) Soft Capsule, is used to treat cardiovascular diseases and is made from a precious Chinese herb known as Sanchi combined with modern pharmaceutical methods. China Shenghuo Pharmaceutical Holdings was founded in 1995 and is based in Kunming, China.

Sell -